CClinicalTrials.gg
CompletedNCT03177759LPCUpdated Oct 2, 2019

Living With Prostate Cancer (LPC)

An observational study in Prostate Cancer, sponsored by Vancouver Prostate Centre. Completed at 1 site in Canada. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-10-02.

Sponsored by Vancouver Prostate Centre · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
42
Ages
18 Years and older
Sex
Male
01

Study summary

This is a prospective evaluation to determine the effectiveness of the Prostate Cancer Supportive Care (PCSC) Program's group therapy program, Living with Prostate Cancer (LPC). LPC is an intervention which utilizes a small group format (5-7 participants with 2 leaders and a paraprofessional counselling student) to understand and learn how to manage emotional responses, depressive symptoms, and life stressors associated with prostate cancer. Data for this evaluation will be derived from a focus group (at 3 months) and self-report questionnaires that participants will complete immediately prior to the intervention, immediately following the intervention and at 3, 6, and 12-months post-intervention.

Read the detailed description

The Vancouver Prostate Centre's (VPCs) PCSC Program is designed to address the gap in supportive care for men with prostate cancer (PC), their partners and their families. The evaluation protocol described here is specific to the program called "Living with Prostate Cancer" (LPC) from the Psychooncology module of the PCSC Program. The specific rationale for this module is that many cancer patients will experience significant anxiety or depression at some point along their cancer journey. The module includes private, confidential clinic appointments for PC patients and their spouses/partners, either separately or together, with our registered clinical counsellor, to explore how to cope with difficult emotions such as fear, anxiety, sadness, helplessness, and other signs of emotional distress. The module is now being expanded to include small group discussions. LPC is a group therapy program in which men participate in a guided autobiographical life review through a process that focuses on developing a cohesive working group, learning strategic communication skills, and understanding and learning how to manage difficult emotions and transitional life stressors associated with PC. It also focuses on the processing and integrating of critical events that contribute to the men's present day identity and psychological function and involves the consolidation of the personal learning that occurs. It shifts the focus on transitioning into the future by developing specific individual, family and/or career goals that are reinforced by ongoing support from peers in the group. Finally, post-group referral plans are developed on an individual basis as needed.

The group therapy program includes men with a diagnosis of PC Stages 1 to 3. We will administer validated quantitative tools to assess depression and anxiety, general psychological functioning, and male role norms (masculinity) before, after, and at 3, 6, and 12-months following the program. The meeting 3 months after the program will include a focus group process.

02

Conditions studied

  • Prostate Cancer

Browse trials for

03

In context

Prostatic Neoplasms

6,370 studies on the registry are indexed under Prostatic Neoplasms; 1,400 are open to participants now.

This study's enrollment of 42 is below the median of 200 across 1,181 observational studies indexed under Prostatic Neoplasms.

Browse Prostatic Neoplasms studies →

Lead sponsor

Vancouver Prostate Centre is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The LPC Workshops will only include men with a diagnosis of Prostate Cancer Stages 1 to 3.

Inclusion criteria

Men are eligible to participate in this evaluation if they:

  • are older than 18 years old
  • are willing to attend the "Living with Prostate Cancer" group therapy sessions from the PCSC Program*
  • are able to speak and read English such that they are able to understand the questionnaires
  • have unimpaired cognitive function with an ability to understand the nature of the study
  • are willing to complete questionnaires at 5 time points
  • provide written informed consent

    • to be able to participate in LPC groups, men must have recently received a diagnosis of PC Stages 1 to 3, or have recently been recommended to undergo a form of treatment following a period of active surveillance.

Exclusion criteria

Exclusion Criteria:

Men will be ineligible to participate in this evaluation if they:

  • have difficulties reading or understanding English
  • have psychotic symptoms, current severe alcohol or other drug dependence, unwillingness to refrain from substance use during the program, and/or significant cognitive impairment that would prevent them participating or providing full informed consent.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
42 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Changes in depressive and anxiety symptoms

    Measured by the Beck Depression Inventory

    Time frame: Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

Secondary outcomes

  1. Changes in overall well-being

    Measured by the Warwick-Edinburgh Mental Wellbeing Scale

    Time frame: Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

  2. Changes in perceptions of masculinity

    Measured by the Personal Attributes Questionnaire

    Time frame: Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

  3. Changes in perceptions of masculinity

    Measured by the Masculine Behaviour Scale

    Time frame: Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

  4. Group cohesion and dynamics

    Measured by the Group Questionnaire

    Time frame: 3-Weeks (Post-workshop), 3-, 6- and 12 Months

  5. Patient-incurred costs for attending the session

    Measured by an annotated cost questionnaire for completion by patients

    Time frame: 3-Weeks (Post-Workshop)

07

Study locations

1 site
  • Vancouver Prostate Centre
    Vancouver, British Columbia V5Z 1M9, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03177759
Lead sponsor
Vancouver Prostate Centre
Responsible party
Sponsor
First posted
Jun 6, 2017
Start date
Sep 9, 2016
Primary completion
Jun 30, 2019
Completion
Aug 31, 2019
Last update
Oct 2, 2019

Study contacts

David Kuhl, MD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion